Comment on "Pre-hospital antiplatelet medication use on COVID-19 disease severity".

Nadeem, Arsalan; Ejaz, Zoya

Nadeem, Arsalan; Ejaz, Zoya.

Nadeem A; Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan. Electronic address: arsalannadeemh@gmail.com.
Ejaz Z; Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan. Electronic address: zoyaejaz171@gmail.com.

Heart Lung ; 55: 164-165, 2022.

Article in English | MEDLINE | ID: covidwho-1814484

Subject(s)

COVID-19; Hospitals; Humans; Platelet Aggregation Inhibitors/therapeutic use; SARS-CoV-2; Severity of Illness Index

Keywords

Antiplatelet; COVID-19; D-dimer; Ethnicity; Mortality

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Heart Lung Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google